Michael Schweizer
University of Washington
H-index: 37
North America-United States
Top articles of Michael Schweizer
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Association of prior poly (ADP-ribose) polymerase (PARP) inhibitor therapy with response to 177Lu-PSMA-617 (LuPSMA) in men with DNA damage repair (DDR) mutations. | Ruben Raychaudhuri George Mo Abuzar Moradi Tuchayi Laura Graham Roman Gulati | 2024/2/1 | |
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1 | Clinical Cancer Research | Neeraj Agarwal Daniel Castellano Teresa Alonso-Gordoa Jose Angel Arranz Arija Emeline Colomba | 2024/4/10 |
Association between SPECT/CT total tumor volume (TTV) and new lesions (NLs) in early cycles of 177Lu-PSMA-617 (LuPSMA) and progression-free and overall … | Ridvan Arda Demirci Roman Gulati Peter Nelson Heather H Cheng Jessica E Hawley | 2024/2/1 | |
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study | JCO Precision Oncology | Ruben Raychaudhuri George Mo Abuzar Moradi Tuchayi Laura Graham Roman Gulati | 2024/4 |
Association between PET-based TheraP eligibility and 177Lu-PSMA-617 (LuPSMA) outcomes in VISION-eligible patients with metastatic castration-resistant … | Ridvan Arda Demirci Roman Gulati Alireza Ghodsi Peter Nelson Heather H Cheng | 2024/2/1 | |
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations | JCO Precision Oncology | Joseph J Park Alec Chu Jinju Li Alicia Ali Rana R McKay | 2024/4 |
Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer | The Prostate | Mark P Labrecque Lisha G Brown Ilsa M Coleman Holly M Nguyen Susan Dalrymple | 2024/1 |
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration | Prostate Cancer and Prostatic Diseases | Zeynep B Zengin Nicholas C Henderson Joseph J Park Alicia Ali Charles Nguyen | 2024/2/22 |
MP35-18 AGREEMENT BETWEEN TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) AND RADICAL CYSTECTOMY (RC) PATHOLOGY IN PATIENTS WITH BLADDER CANCER SUBTYPE HISTOLOGY | The Journal of Urology | Dimitra Rafailia Bakaloudi Elizabeth L Koehne Dimitrios Makrakis Leonidas N Diamandopoulos Petros Grivas | 2024/5 |
The impact of SPOP gene alterations in men with metastatic prostate cancer: Results from the Prostate Cancer Precision Medicine Multi-Institutional Collaborative … | Kyra Lee Yamamoto Nicholas Henderson Clara Hwang Pedro C Barata Mehmet Asim Bilen | 2024/2/1 | |
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer | European Urology Oncology | Jacob J Orme Fadi Taza Navonil De Sarkar Alok K Tewari Syed Arsalan Naqvi | 2023/12/9 |
Internet-based germline genetic testing for men with metastatic prostate cancer | JCO Precision Oncology | Heather H Cheng Alexandra O Sokolova Roman Gulati Deborah Bowen Sarah A Knerr | 2023/1 |
A multi-center, open-label, randomized dose expansion study of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in patients with metastatic … | Mariona Calvo Konstantin Penkov Alexander I Spira Irene Moreno Candilejo Neal D Shore | 2023/2/20 | |
PSMA expression and response to 177Lu-PSMA-617 (LuPSMA) in men with vs. without DNA damage repair (DDR) mutations. | Ruben Raychaudhuri George Mo Michael C Haffner Colm Morrissey Gavin Ha | 2023/6/1 | |
Evaluation of initial prostate cancer biopsies utilizing 3D open‐top light‐sheet microscopy for detection of early disease | The Prostate | George Mo Nicholas P Reder Michael T Schweizer | 2023/8 |
MP50-14 A MULTICENTER EVALUATION OF THE PROGNOSTIC UTILITY OF CHANGES IN TREATMENT-ASSOCIATED BODY COMPOSITION IN MEN WITH GERM CELL TUMORS (GCT) OF THE TESTIS: IMPLICATIONS … | The Journal of Urology | Claire Buxton Benjamin N Schmeusser Sarah K Holt Datta Patil Anthea Phuong | 2023/4 |
155P A phase I study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor INCB099280 in select advanced solid tumors | Immuno-Oncology and Technology | H Prenen T Lesimple M Robert JP Machiels BR Delafontaine | 2023/12/1 |
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 | JAMA oncology | Ziad Bakouny Chris Labaki Punita Grover Joy Awosika Shuchi Gulati | 2023/1/1 |
Clinical implications of Wnt signaling alterations in patients (pts) with advanced prostate cancer (aPC). | Amanda Broderick Jinju Li Alec Chu Clara Hwang Pedro C Barata | 2023/2/20 | |
Phase 1 study of safety and preliminary clinical activity of JNJ-63898081, a PSMA and CD3 bispecific antibody, for metastatic castration-resistant prostate cancer | Clinical Genitourinary Cancer | Emerson A Lim Michael T Schweizer Kim N Chi Rahul Aggarwal Neeraj Agarwal | 2023/6/1 |
